{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T07:49:19Z","timestamp":1777362559564,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000646","name":"JSPS","doi-asserted-by":"publisher","award":["26713002"],"award-info":[{"award-number":["26713002"]}],"id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000646","name":"JSPS","doi-asserted-by":"publisher","award":["26560231"],"award-info":[{"award-number":["26560231"]}],"id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.jconrel.2014.10.007","type":"journal-article","created":{"date-parts":[[2014,10,12]],"date-time":"2014-10-12T10:15:38Z","timestamp":1413108938000},"page":"161-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Mechanism responsible for the antitumor effect of BCG-CWS using the LEEL method in a mouse bladder cancer model"],"prefix":"10.1016","volume":"196","author":[{"given":"Takashi","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Fukiage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiteru","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuya","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Akaza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyoshi","family":"Harashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2014.10.007_bb0005","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0140-6736(98)07422-4","article-title":"BCG immunotherapy of bladder cancer: 20years on","volume":"353","author":"Alexandroff","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2014.10.007_bb0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/cas.12075","article-title":"Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: current understanding and perspectives on engineered BCG vaccine","volume":"104","author":"Kawai","year":"2013","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jconrel.2014.10.007_bb0015","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0022-5347(17)37316-0","article-title":"Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer","volume":"147","author":"Lamm","year":"1992","journal-title":"J. Urol."},{"key":"10.1016\/j.jconrel.2014.10.007_bb0020","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S1567-5769(01)00055-8","article-title":"Development of immunoadjuvants for immunotherapy of cancer","volume":"1","author":"Azuma","year":"2001","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2014.10.007_bb0025","doi-asserted-by":"crossref","first-page":"12992","DOI":"10.1074\/jbc.M800222200","article-title":"The identification and location of succinyl residues and the characterization of the interior arabinan region allow for a model of the complete primary structure of Mycobacterium tuberculosis mycolyl arabinogalactan","volume":"283","author":"Bhamidi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2014.10.007_bb0030","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.1128\/IAI.68.12.6883-6890.2000","article-title":"Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Gu\u00e9rin: involvement of toll-like receptors","volume":"68","author":"Tsuji","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jconrel.2014.10.007_bb0035","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1158\/0008-5472.CAN-03-1518","article-title":"Adjuvant-mediated tumor regression and tumor-specific cytotoxic response are impaired in MyD88-deficient mice","volume":"64","author":"Akazawa","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2014.10.007_bb0040","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1111\/j.1349-7006.2008.00832.x","article-title":"Activation of Toll-like receptor 2 by a novel preparation of cell wall skeleton from Mycobacterium bovis BCG Tokyo (SMP-105) sufficiently enhances immune responses against tumors","volume":"99","author":"Murata","year":"2008","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jconrel.2014.10.007_bb0045","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jconrel.2013.12.027","article-title":"Nanoparticulation of BCG-CWS for application to bladder cancer therapy","volume":"176","author":"Nakamura","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.10.007_bb0050","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrurol.2014.15","article-title":"The mechanism of action of BCG therapy for bladder cancer\u2014a current perspective","volume":"11","author":"Redelman-Sidi","year":"2014","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.jconrel.2014.10.007_bb0055","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/1097-0215(20000915)87:6<844::AID-IJC14>3.0.CO;2-5","article-title":"What are the immunologically active components of bacille Calmette-Gu\u00e9rin in therapy of superficial bladder cancer?","volume":"87","author":"Zlotta","year":"2000","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2014.10.007_bb0060","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0022-5347(01)61832-9","article-title":"Effects of bacillus Calmette-Guerin and interferon alpha-2B on cytokine production in human bladder cancer cell lines","volume":"161","author":"Zhang","year":"1999","journal-title":"J. Urol."},{"key":"10.1016\/j.jconrel.2014.10.007_bb0065","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1442-2042.2002.00415.x","article-title":"Surface antigen expression on bladder tumor cells induced by bacillus Calmette-Gu\u00e9rin (BCG): a role of BCG internalization into tumor cells","volume":"9","author":"Ikeda","year":"2002","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.jconrel.2014.10.007_bb0070","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ijc.26413","article-title":"Fibronectin attachment protein from bacillus Calmette-Guerin as targeting agent for bladder tumor cells","volume":"131","author":"Coon","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2014.10.007_bb0075","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/mt.2008.122","article-title":"Efficient MHC class I presentation by controlled intracellular trafficking of antigens in octaarginine-modified liposomes","volume":"16","author":"Nakamura","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2014.10.007_bb0080","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1248\/bpb.34.1348","article-title":"A20 silencing by lipid envelope-type nanoparticles enhances the efficiency of lipopolysaccharide-activated dendritic cells","volume":"34","author":"Warashina","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2014.10.007_bb0085","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2490-5-8","article-title":"BCG directly induces cell cycle arrest in human transitional carcinoma cell lines as a consequence of integrin cross-linking","volume":"5","author":"Chen","year":"2005","journal-title":"BMC Urol."},{"key":"10.1016\/j.jconrel.2014.10.007_bb0090","first-page":"697","article-title":"Bacillus-calmette-guerin (bcg) organisms directly alter the growth of bladder-tumor cells","volume":"5","author":"Jackson","year":"1994","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jconrel.2014.10.007_bb0095","first-page":"1315","article-title":"Internalization of Mycobacterium bovis, Bacillus Calmette Guerin, by bladder cancer cells is cytotoxic","volume":"18","author":"Pook","year":"2007","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jconrel.2014.10.007_bb0100","first-page":"4286","article-title":"Murine bladder carcinoma cells present antigen to BCG-specific CD4+ T-cells","volume":"52","author":"Lattime","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2014.10.007_bb0105","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.4049\/jimmunol.172.4.2382","article-title":"The crystal structure of human CD1b with a bound bacterial glycolipid","volume":"172","author":"Batuwangala","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2014.10.007_bb0110","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1126\/science.278.5336.283","article-title":"Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells","volume":"278","author":"Moody","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2014.10.007_bb0115","doi-asserted-by":"crossref","first-page":"16800","DOI":"10.1074\/jbc.M110.217224","article-title":"A microbial glycolipid functions as a new class of target antigen for delayed-type hypersensitivity","volume":"286","author":"Komori","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2014.10.007_bb0120","first-page":"119","article-title":"Immunotherapy of cancer: regression of intradermal tumors and prevention of growth of lymph node metastases after intralesional injection of living Mycobacterium bovis","volume":"49","author":"Zbar","year":"1972","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jconrel.2014.10.007_bb0125","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc3258","article-title":"Cancer immunotherapy via dendritic cells","volume":"12","author":"Palucka","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2014.10.007_bb0130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0022-5347(17)43909-7","article-title":"Requirement of a thymus dependent immune response for BCG-mediated antitumor activity","volume":"137","author":"Ratliff","year":"1987","journal-title":"J. Urol."},{"key":"10.1016\/j.jconrel.2014.10.007_bb0135","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0022-5347(17)35678-1","article-title":"T-cell subsets required for intravesical BCG immunotherapy for bladder cancer","volume":"150","author":"Ratliff","year":"1993","journal-title":"J. Urol."},{"key":"10.1016\/j.jconrel.2014.10.007_bb0140","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/1097-0215(20010601)92:5<697::AID-IJC1245>3.0.CO;2-Z","article-title":"NK cells are essential for effective BCG immunotherapy","volume":"92","author":"Brandau","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2014.10.007_bb0145","doi-asserted-by":"crossref","first-page":"8250","DOI":"10.1158\/0008-5472.CAN-06-1416","article-title":"Neutrophil granulocytes are required for effective Bacillus Calmette-Guerin immunotherapy of bladder cancer and orchestrate local immune responses","volume":"66","author":"Suttmann","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2014.10.007_bb0150","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1158\/0008-5472.CAN-12-1882","article-title":"Oncogenic activation of Pak1-dependent pathway of macropinocytosis determines BCG entry into bladder cancer cells","volume":"73","author":"Redelman-Sidi","year":"2013","journal-title":"Cancer Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365914006828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365914006828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T23:34:24Z","timestamp":1565912064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365914006828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":30,"alternative-id":["S0168365914006828"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2014.10.007","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism responsible for the antitumor effect of BCG-CWS using the LEEL method in a mouse bladder cancer model","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2014.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}